Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1997 Dec;20(6):354-7.

[Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis]

[Article in Chinese]
Y Zhang  1 , H Qian, M Chen
Affiliations
  • PMID: 10374446
Clinical Trial

[Bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis]

[Article in Chinese]
Y Zhang et al. Zhonghua Jie He He Hu Xi Za Zhi. 1997 Dec.

Abstract

Objective: To evaluate the clinical value of bronchofiberscope and catheter intervention in treatment of multi-drug resistant pulmonary tuberculosis.

Method: Forty-eight patients with multi-drug resistant pulmonary tuberculosis were treated by injecting ofloxacin and amikacin through bronchofiberscope and catheter in addition to chemotherapy, while forty controls were treated by chemotherapy only.

Result: At the end of the treatment, the sputum conversion rate was 92%, radiographic improvement rate 96% and cavity closing rate 27% in the treatment group, all of which were higher than the controls (63%, 58% and 10% respectively) (P < 0.01-0.05). No complication and obvious adverse reaction were observed.

Conclusion: The efficacy of bronchofiberscope and catheter intervention in addition to chemotherapy is better than only chemotherapy in treatment of multi-drug resistant pulmonary tuberculosis.

PubMed Disclaimer